University of Eastern Piedmont
3 clinical trials · Sponsor
◉ Watch University of Eastern Piedmont
| Record | Firm | Date |
|---|---|---|
| Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT) (NCT06928701) | University of Eastern Piedmont | 2024-09-01 |
Track University of Eastern Piedmont automatically
Every clearance here is in the API, with alerts when new ones post.